Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 5
2005 7
2006 4
2007 5
2008 4
2009 4
2010 9
2011 6
2012 13
2013 11
2014 13
2015 10
2016 18
2017 11
2018 8
2019 16
2020 12
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

150 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean jinghong liu (47 results)?
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial.
Ren H, Li X, Ni ZH, Niu JY, Cao B, Xu J, Cheng H, Tu XW, Ren AM, Hu Y, Xing CY, Liu YH, Li YF, Cen J, Zhou R, Xu XD, Qiu XH, Chen N. Ren H, et al. Int Urol Nephrol. 2017 Mar;49(3):499-507. doi: 10.1007/s11255-017-1507-0. Epub 2017 Jan 20. Int Urol Nephrol. 2017. PMID: 28108978 Free PMC article. Clinical Trial.
The miR164-dependent regulatory pathway in developing maize seed.
Zheng L, Zhang X, Zhang H, Gu Y, Huang X, Huang H, Liu H, Zhang J, Hu Y, Li Y, Yu G, Liu Y, Lawson SS, Huang Y. Zheng L, et al. Among authors: liu y. Mol Genet Genomics. 2019 Apr;294(2):501-517. doi: 10.1007/s00438-018-1524-4. Epub 2019 Jan 3. Mol Genet Genomics. 2019. PMID: 30607602
150 results